BullFrog AI (BFRG) stock jumped 106% after announcing a drug discovery deal with a top-5 pharma firm targeting major ...

BullFrog AI (BFRG) stock surged 101% after securing a commercial partnership with a top 5 pharma company for depression drug target identification.

Multiple SIRS presentations underscore the potential of LB-102 to address positive, negative, and cognitive symptom domains ...

Reported positive results from potentially registrational Phase 2 trial ofLB-102 in schizophrenia Advanced LB-102 into late-stage development in multiple indications with initiation ofa pivotal Phase ...

Science Translational Medicine Features GlyphAllo™: First Triglyceride-Mimetic Prodrug to Achieve Therapeutically Relevant ...